Appointment of Chief Technology Officer

05 Aug 2024 11:20 CEST

Moss 5 August, 2024

Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic
tests, is pleased to announce the appointment of Frank Frantzen as Chief
Technology Officer (CTO).

Frank Frantzen has more than 35 years of experience from the diagnostic
industry. He has served as principal scientist and has directed larger R&D units
in the international IVD companies Axis-Shield, Alere and Abbott. Mr. Frantzen
left his Senior Director R&D position at Abbott in 2021 and has until recently
served as Chief Technology Officer in CardiNor AS. Mr. Frantzen also served as a
board member of Gentian Diagnostics from May 2022 to December 2023.

Mr. Frank Frantzen holds a master’s degree in chemistry and a Ph.D. (Dr.philos.)
in chemistry/biotechnology/IVD-technology, both from the Norwegian University of
Science and Technology in Trondheim.

Over the years, Frank has been involved in launching several international
blockbuster IVD products, with homocysteine and the Afinion POC system
(instrument and assays) as examples. In 2019, Frank was awarded the Abbott’s
Scientific Governing Board Innovation Award for his work on the analysis of
HbA1c, the principal marker for diagnosis of diabetes. He was the same year also
introduced into Abbott's Volwiler Society, an honorary society for Abbotts most
distinguished scientists and engineers.

About Gentian Diagnostics
Gentian Diagnostics (OSE: GENT), develops and manufactures high-quality, in
vitro diagnostic reagents. Gentian’s expertise and focus lies within homogenous
immunoassays, specifically infections, inflammations, kidney failures and
congestive heart failures. By converting existing and clinically relevant
biomarkers to the most efficient automated, high-throughput analysers, the
company contributes to saving costs and protecting life. Gentian is
headquartered in Moss, Norway, serving the global human and veterinary
diagnostics markets through sales and representative offices in Sweden, USA, and
China. For more information, please visit www.gentian.com.

IR contact:
Njaal Kind, CEO
njaal.kind@gentian.no
+47 919 06 525 (mobile)

More information:
Access the news on Oslo Bors NewsWeb site